Key facts
- It has raised $500K across 1 recorded rounds; the latest was Seed Round ($500K) in Aug 2025.
- Teleios Analytical Services has filed 1 Form D with the SEC, most recently Sep 2025 ($500K sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Teleios Analytical Services
Funding rounds
1 roundsAbout Teleios Analytical Services
Operator of a quality analytical testing platform intended for the pharmaceutical, biotech, and medical device industries. The company's services include impurity testing, solvents testing, extractables and leachables studies, glass delamination studies, and method development, enabling research and healthcare industries to get precise and reliable results that support product safety and regulatory compliance.
- Sector
- Healthcare
- HQ
- Mansfield, MA, United States
- Founded
- 2025
- Website
- teleios-labs.com/
- Ownership
- Privately Held (backing)
Teleios Analytical Services doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Teleios Analytical Services shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Teleios Analytical Services in its N-PORT filings yet. We sweep new filings monthly.